Question 1

What is Xolair?

Accepted Answer

Xolair is a laboratory-made protein known as a monoclonal antibody. It works by binding to immunoglobulin E (IgE), a specific antibody produced by the immune system that triggers allergic and inflammatory responses.

By blocking IgE from attaching to receptors on certain immune cells, the medication helps limit the release of chemical mediators that cause symptoms in the body. This therapeutic approach focuses on managing the underlying biological activity associated with certain chronic conditions where the immune system is overactive.

Question 2

What is Xolair used for?

Accepted Answer

Xolair is used to treat chronic spontaneous urticaria , nasal polyps , and persistent asthma .

Question 3

How does Xolair work?

Accepted Answer

Mechanism of Action

Xolair (omalizumab) is designed to target and bind to immunoglobulin E (IgE). IgE is a type of antibody produced by the immune system that plays a central role in allergic responses. When a person with allergies is exposed to a trigger—such as pollen, dust mites, or certain foods—their body produces IgE, which then attaches to specific immune cells called mast cells and basophils.

By binding to the IgE circulating in the blood, Xolair prevents it from attaching to these immune cells. This process helps in several ways:

Reducing Chemical Release: Because the IgE cannot attach to the immune cells, those cells are less likely to release histamine and other chemicals that cause inflammation and allergic symptoms.

Lowering Sensitivity: Over time, treatment can decrease the number of IgE receptors on the surface of immune cells, making the body less sensitive to allergens.

Preventing Severe Reactions: In cases of food allergies, blocking IgE helps increase the amount of an allergen a person can be exposed to before a severe reaction occurs.

For conditions like chronic hives, Xolair works by limiting the activation of the immune pathways that cause itchy skin welts, even when a specific external trigger is not identified.

Question 4

What are the active ingredients in Xolair?

Accepted Answer

The active ingredient in Xolair is omalizumab .

Question 5

What are the side effects of Xolair?

Accepted Answer

Common side effects of Xolair may include:

injection site reactions

headache

upper respiratory infection

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Xolair?

Accepted Answer

Xolair belongs to the monoclonal antibody anti-IgE drug class.

Question 7

What is the dosage of Xolair and how do I take it?

Accepted Answer

Administration

Xolair is given as a subcutaneous injection, which is an injection into the fatty tissue just under the skin. The frequency of injections is usually once every two weeks or once every four weeks, depending on the condition being treated and the patient's specific needs.

Initial doses are often administered by a healthcare professional in a medical setting. Once your doctor determines it is appropriate, you or a caregiver may be trained to give the injections at home using a prefilled syringe or autoinjector.

How to Take

If using the medication at home, take it out of the refrigerator and allow it to reach room temperature before injecting.

Do not shake the medication.

Injections should be given in the thigh, abdomen, or the outer area of the upper arm.

Rotate the injection site with each dose. Avoid areas where the skin is bruised, red, or hard.

Missed Dose

If you miss a dose or an appointment for an injection, contact your healthcare provider as soon as possible to reschedule. Do not attempt to double the dose to make up for the one you missed.

Question 8

Is Xolair safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the safety of using Xolair during pregnancy. It is not yet known if the medication can cause harm to an unborn baby. Because of this uncertainty, healthcare providers typically evaluate whether the benefits of the medication for the mother outweigh the potential risks to the fetus.

A pregnancy registry exists to monitor the outcomes of individuals who use Xolair while pregnant. This registry helps researchers and healthcare professionals better understand the drug's effects on pregnancy and infant health.

Breastfeeding

It is unknown if Xolair passes into human breast milk or how it might affect a nursing infant. Because many medications are excreted in breast milk, it is important for patients to discuss breastfeeding with their healthcare provider. They can help weigh the necessity of the medication against any potential risks to the baby.

Question 9

What forms and strengths does Xolair come in?

Accepted Answer

Available Forms

Xolair is administered as a subcutaneous injection. It is available in the following formats:

Prefilled Syringe: A syringe for manual administration.

Autoinjector: A device for administration.

Vial: A vial containing a powder that must be mixed with liquid by a healthcare professional before it is injected.

Question 10

What is the FDA approval status of Xolair?

Accepted Answer

FDA Approval and Indications

Xolair was first approved by the U.S. Food and Drug Administration (FDA) in 2003. It is currently authorized for several specific uses:

Allergic Asthma: For adults and children 6 years of age and older with moderate-to-severe persistent asthma that is not well-controlled by inhaled corticosteroids.

Chronic Spontaneous Urticaria (CSU): For adults and adolescents 12 years of age and older who continue to experience hives without a known cause despite antihistamine treatment.

Nasal Polyps: For adults with chronic rhinosinusitis with nasal polyps when steroid nasal sprays have not worked well enough.

Food Allergies: Approved in 2024 to help reduce the risk of severe allergic reactions, including anaphylaxis, following accidental exposure to one or more foods in adults and children aged 1 year and older.

Boxed Warning

The FDA has issued a boxed warning for Xolair due to the risk of anaphylaxis, a sudden and life-threatening allergic reaction. This reaction can occur after the first dose or after many doses, and it may happen immediately or several hours after the injection. Because of this risk, the medication must be administered in a healthcare setting for the initial doses, and patients are typically prescribed an epinephrine auto-injector for emergency use at home.

Safety Communications

The FDA has monitored the long-term safety of Xolair through post-market reviews. This includes investigations into a potential increased risk of serious cardiovascular and cerebrovascular events, such as heart attacks, mini-strokes, or blood clots in the lungs and veins. While the evidence for these risks was not conclusive, they are noted in the drug's safety labeling to inform providers and patients.

Question 11

What should I know about Xolair and cost?

Accepted Answer

Insurance and Coverage

Xolair is classified as a specialty biologic medication. Because of this classification, most insurance plans, including private insurance and Medicare, typically require prior authorization before they will cover the cost. The amount you pay out-of-pocket will depend on your specific plan's deductible, co-payment, or coinsurance requirements for specialty drugs.

Administration Costs

The total cost of treatment may be affected by where the medication is administered. Xolair can be given by a healthcare professional in a medical office or, in some cases, self-injected by the patient at home. If the medication is administered in a clinic, there may be additional costs associated with the office visit and the professional services required to give the injection.

Dosage and Frequency

The price of therapy varies between individuals because the dosage is not the same for everyone. For many conditions, a healthcare provider determines the dose based on the patient's body weight and the results of blood tests that measure immunoglobulin E (IgE) levels. Patients who require higher doses or more frequent injections will have higher overall treatment costs than those on a lower-dose schedule.

Financial Assistance

For patients who are concerned about the cost of Xolair, there may be financial assistance programs available. These can include manufacturer-sponsored support for those with commercial insurance or programs for individuals who are uninsured or underinsured. Patients should discuss these options with their healthcare provider or specialty pharmacy.

Xolair

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?